Category: Press Release

bonyf enters a new era of “Renaissance” driven by its own brands and the international launch of PerioCream
Post

bonyf enters a new era of “Renaissance” driven by its own brands and the international launch of PerioCream

Knokke-Heist (Belgium), 31 August 2026, 6:00 a.m.; bonyf NV (Ticker: MLBON), a leader in dental consumer goods, professional dental consumables and dermatological solutions, describes the strategic transformation undertaken by the Group as the “Renaissance of bonyf”: a return to the entrepreneurial and brand-focused approach that drove the Company’s strongest years between 1980 and 2000.

bonyf NV Annual General Meeting Approves 2025 Financial Statements and Reaffirms Growth Strategy
Post

bonyf NV Annual General Meeting Approves 2025 Financial Statements and Reaffirms Growth Strategy

Knokke-Heist (Belgium), 30 June 2026, 6:00 a.m.; bonyf NV (Ticker: MLBON), a leader in dental consumer goods, professional dental consumables and dermatological solutions, held its Annual General Meeting on 25 June 2026 in Knokke, Belgium. The meeting was well attended, and all resolutions submitted to the shareholders were approved. The 2025 financial statements of bonyf NV, which have already been published through Euronext, were unanimously approved by the shareholders present.

bonyf NV – Annual General Meeting Date and Business Update
Post

bonyf NV – Annual General Meeting Date and Business Update

Knokke-Heist (Belgium), 24 April 2026, 6:00 a.m.; bonyf NV (Ticker: MLBON), a leading innovator in oral and dental care. As previously communicated to our shareholders through our earlier Euronext announcement regarding the change of date of the Annual General Meeting (“AGM”) of bonyf NV, we are pleased to confirm that the AGM will take place on 25 June 2026 at 10:00 AM in Knokke, Belgium.

bonyf – A Year of Certification, Innovation and Commercial Acceleration
Post

bonyf – A Year of Certification, Innovation and Commercial Acceleration

Knokke-Heist (Belgium), 27 January 2026, 6:00 a.m.; bonyf NV (Euronext Paris Ticker: MLBON), a leading innovator in oral and dental care, today provides an update on the year 2025 which has been a decisive period, marked by regulatory achievements, sustained innovation and accelerating commercial momentum. In an environment shaped by increasingly stringent European regulations and rising international standards, bonyf has reinforced its position as a compliant, innovation-driven medical device group.

Company Update on Market Trading Dynamics and Business Fundamentals
Post

Company Update on Market Trading Dynamics and Business Fundamentals

Knokke-Heist (Belgium), 22 December 2025, 6:00 a.m.; bonyf NV (Euronext Paris Ticker: MLBON), a leading innovator in oral and dental care, today provides a clarification regarding recent share price movements and trading liquidity, emphasizing that these market dynamics do not reflect the Company’s underlying operational performance or financial health.

PerioCream becomes the most in-demand bonyf innovation
Post

PerioCream becomes the most in-demand bonyf innovation

Knokke-Heist (Belgium), 24 November 2025, 6:00 a.m.; bonyf NV (Euronext Paris Ticker: MLBON), a leader in dental consumer goods, professional dental consumables and dermatological solutions, announces a faster and successful roll out of its newest dental care innovation namely, PerioCream Periodontal Paste, a mucoadhesive formulation based on NitrAdine®, applied by dental professionals as an adjunct to Scaling and Root Planing (SRP).

bonyf AG receives the EU-MDR Certification Class IIa for PerioCream
Post

bonyf AG receives the EU-MDR Certification Class IIa for PerioCream

Knokke-Heist (Belgium), 15 October 2025, 6:00 a.m.; bonyf NV (Euronext Paris Ticker: MLBON) announces today that its brand, PerioCream, a mucoadhesive formulation based on NitrAdine®, applied by dental professionals as an adjunct to Scaling & Root Planing (SRP) has been granted a certification as a Class IIa medical device according to Medical Device Regulation (EU) 2017/745 Annex IX Chapter I+III.

  • 1
  • 2
  • …
  • 5